Investor's Business Daily on MSN55m
Harmony Biosciences Crashes On Surprise Rejection For Bread-And-Butter DrugHarmony Sciences shares plunged Wednesday after the FDA rejected its bread-and-butter drug as a treatment for a daytime sleepiness condition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback